SPI1 and Huntington disease: Additionally, mutant Huntingtin aggregates present in Huntington’s disease enhance microglial activation through PU.1 [35], as do hypoxic-ischaemic insults [36], suggesting that PU.1 modulation may be a common feature underlying distinct neurological disorders.